Administration of docetaxel plus ramucirumab with primary prophylactic pegylated-granulocyte colony-stimulating factor for pretreated non-small cell lung cancer: a phase II study.
Kasahara N, Sunaga N, Kuwako T, Naruse I, Imai H, Jingu A, Tsukagoshi Y, Masuda T, Kitahara S, Tsurumaki H, Yatomi M, Hara K, Koga Y, Sakurai R, Mori K, Kaira K, Maeno T, Asao T, Hisada T.
Kasahara N, et al. Among authors: jingu a.
Support Care Cancer. 2020 Oct;28(10):4825-4831. doi: 10.1007/s00520-020-05317-z. Epub 2020 Jan 25.
Support Care Cancer. 2020.
PMID: 31982960
Clinical Trial.